- Home
- CHE vs PCVX Comparison
CHE vs PCVX Comparison
Compare CHE & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHE
- PCVX
- Stock Information
- Founded
- CHE 1970
- PCVX 2013
- Country
- CHE United States
- PCVX United States
- Employees
- CHE N/A
- PCVX N/A
- Industry
- CHE Medical/Nursing Services
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- CHE Health Care
- PCVX Health Care
- Exchange
- CHE Nasdaq
- PCVX Nasdaq
- Market Cap
- CHE 8.0B
- PCVX 13.2B
- IPO Year
- CHE N/A
- PCVX 2020
- Fundamental
- Price
- CHE $533.96
- PCVX $78.14
- Analyst Decision
- CHE Buy
- PCVX Strong Buy
- Analyst Count
- CHE 2
- PCVX 9
- Target Price
- CHE $641.50
- PCVX $149.38
- AVG Volume (30 Days)
- CHE 100.0K
- PCVX 1.1M
- Earning Date
- CHE 02-25-2025
- PCVX 02-25-2025
- Dividend Yield
- CHE 0.34%
- PCVX N/A
- EPS Growth
- CHE 22.57
- PCVX N/A
- EPS
- CHE 19.78
- PCVX N/A
- Revenue
- CHE $2,377,206,000.00
- PCVX N/A
- Revenue This Year
- CHE $8.28
- PCVX N/A
- Revenue Next Year
- CHE $7.06
- PCVX N/A
- P/E Ratio
- CHE $26.99
- PCVX N/A
- Revenue Growth
- CHE 6.83
- PCVX N/A
- 52 Week Low
- CHE $512.12
- PCVX $58.10
- 52 Week High
- CHE $654.62
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- CHE 48.79
- PCVX 32.14
- Support Level
- CHE $520.16
- PCVX $80.10
- Resistance Level
- CHE $535.09
- PCVX $81.70
- Average True Range (ATR)
- CHE 9.17
- PCVX 3.12
- MACD
- CHE 1.99
- PCVX -0.13
- Stochastic Oscillator
- CHE 83.42
- PCVX 5.68
About CHE Chemed Corp
Chemed Corp operates subsidiaries in two main segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue. It provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The vast majority of the segment's revenue is received from the Medicare and Medicaid reimbursement programs. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers. Chemed generates the majority of its revenue from business in the United States.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.